Vessel-Specific Toll-Like Receptor Profiles in Human Medium and Large Arteries

Background— Inflammatory vasculopathies, ranging from the vasculitides (Takayasu arteritis, giant cell arteritis, and polyarteritis nodosa) to atherosclerosis, display remarkable target tissue tropisms for selected vascular beds. Molecular mechanisms directing wall inflammation to restricted anatomic sites within the vascular tree are not understood. We have examined the ability of 6 different human macrovessels (aorta and subclavian, carotid, mesenteric, iliac, and temporal arteries) to initiate innate and adaptive immune responses by comparing pathogen-sensing and T-cell-stimulatory capacities. Methods and Results— Gene expression analysis for pathogen-sensing Toll-like receptors (TLRs) 1 to 9 showed vessel-specific profiles, with TLR2 and TLR4 ubiquitously present, TLR7 and TLR9 infrequent, and TLR1, TLR3, TLR5, TLR6, and TLR8 expressed in selective patterns. Experiments with vessel walls stripped of the intimal or adventitial layer identified dendritic cells at the media-adventitia junction as the dominant pathogen sensors. In human artery-severe combined immunodeficiency (SCID) mouse chimeras, adoptively transferred human T cells initiated vessel wall inflammation if wall-embedded dendritic cells were conditioned with TLR ligands. Wall-infiltrating T cells displayed vessel-specific activation profiles with differential production of CD40L, lymphotoxin-&agr;, and interferon-&ggr;. Vascular bed-specific TLR fingerprints were functionally relevant, as exemplified by differential responsiveness of iliac and subclavian vessels to TLR5 but not TLR4 ligands. Conclusions— Populated by indigenous dendritic cells, medium and large human arteries have immune-sensing and T-cell-stimulatory functions. Each vessel in the macrovascular tree exhibits a distinct TLR profile and supports selective T-cell responses, imposing vessel-specific risk for inflammatory vasculopathies.

[1]  N. Punchard,et al.  The endothelium and inflammation , 2000, Inflammation Research.

[2]  R. Virmani,et al.  Aortitis and ascending aortic aneurysm: description of 52 cases and proposal of a histologic classification. , 2008, Human pathology.

[3]  H. Virgin,et al.  IFN-γ action in the media of the great elastic arteries, a novel immunoprivileged site , 2001 .

[4]  V. Fuster,et al.  Neovascularization in human atherosclerosis. , 2006, Current molecular medicine.

[5]  C. Weyand,et al.  Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. , 1996, The American journal of pathology.

[6]  H. Niederegger,et al.  Network of Vascular-Associated Dendritic Cells in Intima of Healthy Young Individuals , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[7]  J. Loscalzo,et al.  Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.

[8]  T. Tedder,et al.  Adhesion molecule cascades direct lymphocyte recirculation and leukocyte migration during inflammation , 2000, Immunologic research.

[9]  G. Hoffman Determinants of Vessel Targeting in Vasculitis , 2005, Clinical & developmental immunology.

[10]  K. Moulton Angiogenesis in atherosclerosis: gathering evidence beyond speculation , 2006, Current opinion in lipidology.

[11]  R. Erbel,et al.  Differential distribution of vasa vasorum in different vascular beds in humans. , 2008, Atherosclerosis.

[12]  P. V. Van Schil,et al.  Possible mechanisms of collar-induced intimal thickening. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[13]  F. Meyer,et al.  Functional profile of activated dendritic cells in unstable atherosclerotic plaque , 2007, Basic Research in Cardiology.

[14]  C. Weyand,et al.  Tissue trafficking patterns of effector memory CD4+ T cells in rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[15]  L. Picker,et al.  Physiological and molecular mechanisms of lymphocyte homing. , 1992, Annual review of immunology.

[16]  G. Hansson,et al.  Expression of Toll-Like Receptors in Human Atherosclerotic Lesions: A Possible Pathway for Plaque Activation , 2002, Circulation.

[17]  M. Miyasaka,et al.  Lymphocyte trafficking across high endothelial venules: dogmas and enigmas , 2004, Nature Reviews Immunology.

[18]  T. Tedder,et al.  Activation of Arterial Wall Dendritic Cells and Breakdown of Self-tolerance in Giant Cell Arteritis , 2004, The Journal of experimental medicine.

[19]  E. Chaikof,et al.  Pathogen-Sensing Plasmacytoid Dendritic Cells Stimulate Cytotoxic T-Cell Function in the Atherosclerotic Plaque Through Interferon-&agr; , 2006, Circulation.

[20]  M. Shin,et al.  Synergistic Proinflammatory Effects of the Antiviral Cytokine Interferon-&agr; and Toll-Like Receptor 4 Ligands in the Atherosclerotic Plaque , 2007, Circulation.

[21]  G. Hoffman,et al.  Differentiating the vasculitides. , 1994, Rheumatic diseases clinics of North America.

[22]  Y. Bobryshev,et al.  S-100 positive cells in human arterial intima and in atherosclerotic lesions. , 1995, Cardiovascular research.

[23]  S. Gröschel,et al.  Vascular Dendritic Cells in Giant Cell Arteritis , 2005, Annals of the New York Academy of Sciences.

[24]  C. Schwentner,et al.  The vascular-associated lymphoid tissue: a new site of local immunity , 2001, Current opinion in lipidology.

[25]  P. Zeek Periarteritis Nodosa: A Critical Review , 1952 .

[26]  C. Weyand,et al.  Medium- and large-vessel vasculitis. , 2003, The New England journal of medicine.

[27]  Mildred Kwan,et al.  Toll-like receptors in giant cell arteritis. , 2005, Clinical immunology.

[28]  S Glagov,et al.  Nature of Species Differences in the Medial Distribution of Aortic Vasa Vasorum in Mammals , 1967, Circulation research.

[29]  Francesco D'Aiuto,et al.  Treatment of periodontitis and endothelial function. , 2007, The New England journal of medicine.

[30]  H. Virgin,et al.  IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site. , 2001, The Journal of clinical investigation.

[31]  Transcriptional profile of postmortem skeletal muscle. , 2004, Physiological genomics.

[32]  R. Frye,et al.  TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque , 2006, The Journal of experimental medicine.

[33]  P. Bacon Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects , 2005, Current opinion in rheumatology.

[34]  C. Savage,et al.  Vasculitis in the gastrointestinal tract. , 2005, Best practice & research. Clinical gastroenterology.

[35]  Qingbo Xu,et al.  Atherosclerosis, autoimmunity, and vascular‐associated lymphoid tissue , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  G. Hoffman,et al.  Large-vessel vasculitis: unresolved issues. , 2003, Arthritis and rheumatism.

[37]  B. Tesfamariam,et al.  Endothelial injury in the initiation and progression of vascular disorders. , 2007, Vascular pharmacology.

[38]  E. Fisher,et al.  TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis. , 2006, Trends in immunology.